ArticleRecent patents on anti-cancer drug discovery2024

CK2B is a Prognostic Biomarker and a Potential Drug Target for Hepatocellular Carcinoma.

Huiru Dai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.